Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
409.65
-11.72 (-2.78%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Medpace Holdings Revenue
Medpace Holdings had revenue of $706.60M in the quarter ending March 31, 2026, with 26.50% growth. This brings the company's revenue in the last twelve months to $2.68B, up 24.19% year-over-year. In the year 2025, Medpace Holdings had annual revenue of $2.53B with 19.97% growth.
Revenue (ttm)
$2.68B
Revenue Growth
+24.19%
P/S Ratio
4.37
Revenue / Employee
$431,979
Employees
6,200
Market Cap
11.70B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.53B | 421.18M | 19.97% |
| Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
| Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
| Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
| Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.28B |
| ICON Public Limited Company | 8.10B |
| Illumina | 4.34B |
| Mettler-Toledo International | 4.03B |
| Charles River Laboratories International | 4.02B |
| Revvity | 2.86B |
MEDP News
- 5 days ago - Medpace Flags Rising Cancellations, Near-Term Growth Uncertain - Benzinga
- 5 days ago - Medpace Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Medpace Holdings, Inc. Reports First Quarter 2026 Results - Business Wire
- 13 days ago - MEDP INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit - PRNewsWire
- 15 days ago - Shareholders who lost money in Medpace Holdings, Inc. (NASDAQ: MEDP) Should Contact Wolf Haldenstein Immediately - GlobeNewsWire
- 16 days ago - MEDP INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Medpace Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Action Lawsuit - GlobeNewsWire
- 27 days ago - Medpace Holdings, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 5 weeks ago - Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026 - Business Wire